EAM
BHVN
Eventide Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,129,100
| Closed | -$165M | – | 154 |
|
|
2022
Q2 | $165M | Sell |
1,129,100
-505,900
| -31% | -$73.7M | 3.52% | 1 |
|
|
2022
Q1 | $194M | Hold |
1,635,000
| – | – | 3.04% | 1 |
|
|
2021
Q4 | $225M | Buy |
1,635,000
+310,000
| +23% | +$42.7M | 2.88% | 2 |
|
|
2021
Q3 | $184M | Sell |
1,325,000
-665,797
| -33% | -$92.5M | 2.43% | 6 |
|
|
2021
Q2 | $193M | Sell |
1,990,797
-24,203
| -1% | -$2.35M | 2.6% | 6 |
|
|
2021
Q1 | $138M | Buy |
2,015,000
+231,239
| +13% | +$15.8M | 2.04% | 6 |
|
|
2020
Q4 | $153M | Hold |
1,783,761
| – | – | 2.34% | 8 |
|
|
2020
Q3 | $116M | Hold |
1,783,761
| – | – | 2.27% | 8 |
|
|
2020
Q2 | $130M | Hold |
1,783,761
| – | – | 2.83% | 4 |
|
|
2020
Q1 | $60.7M | Buy |
1,783,761
+149,761
| +9% | +$5.1M | 1.97% | 10 |
|
|
2019
Q4 | $89M | Hold |
1,634,000
| – | – | 2.51% | 6 |
|
|
2019
Q3 | $68.2M | Buy |
1,634,000
+811,000
| +99% | +$33.8M | 2.25% | 9 |
|
|
2019
Q2 | $36M | Buy |
823,000
+330,000
| +67% | +$14.5M | 1.1% | 29 |
|
|
2019
Q1 | $25.4M | Hold |
493,000
| – | – | 0.87% | 39 |
|
|
2018
Q4 | $18.2M | Buy |
493,000
+199,000
| +68% | +$7.36M | 0.81% | 44 |
|
|
2018
Q3 | $11M | Buy |
294,000
+40,000
| +16% | +$1.5M | 0.41% | 71 |
|
|
2018
Q2 | $10M | Sell |
254,000
-92,000
| -27% | -$3.64M | 0.42% | 70 |
|
|
2018
Q1 | $8.91M | Buy |
346,000
+104,000
| +43% | +$2.68M | 0.42% | 68 |
|
|
2017
Q4 | $6.53M | Buy |
242,000
+188,760
| +355% | +$5.09M | 0.34% | 78 |
|
|
2017
Q3 | $1.99M | Hold |
53,240
| – | – | 0.11% | 104 |
|
|
2017
Q2 | $1.33M | Buy |
+53,240
| New | +$1.33M | 0.08% | 107 |
|